+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biological Patch Market - Global Forecast 2026-2032- Product Image
Biological Patch Market - Global Forecast 2026-2032- Product Image
Sale

Biological Patch Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6154604
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biological Patch Market is projected to reach USD 1.30 Billion in 2026. It is expected to continue growing at a CAGR of 8.48%, reaching USD 2.13 Billion by 2032.

Biological Patches: Executive Summary and Strategic Context

Biological patches are engineered or biologically derived materials designed to support tissue repair, regeneration, wound management, or localized therapeutic delivery. Their development sits at the intersection of biomaterials science, regenerative medicine, surgery, drug delivery, and advanced manufacturing. Adoption is shaped by clinical evidence, biocompatibility, handling characteristics, reimbursement conditions, regulatory requirements, and the ability to demonstrate meaningful patient outcomes.

Clinical Integration Is Reshaping the Biological Patch Landscape

The field is moving from conventional coverings and structural repair toward multifunctional patches that can support healing, control the local biological environment, and deliver therapeutic agents. Important shifts include the use of decellularized matrices, naturally derived polymers, bioactive coatings, living-cell approaches, and combination products. These developments increase technical opportunity but also raise validation demands, particularly around sterility, degradation, immune response, shelf life, manufacturing consistency, and long-term clinical performance.

Artificial Intelligence Is Accelerating Design, Testing, and Care Pathways

Artificial intelligence can support biological-patch development by analyzing biomaterials data, identifying formulation patterns, optimizing scaffold architecture, and prioritizing experimental candidates. In clinical and operational settings, AI may assist image interpretation, wound monitoring, patient stratification, and treatment-response assessment. Its value depends on representative datasets, transparent validation, cybersecurity, clinician oversight, and careful separation of research-use tools from regulated clinical decision systems. AI complements rather than replaces laboratory, preclinical, and clinical evidence.

Regional Insights: Regulation, Infrastructure, and Clinical Need Shape Adoption

North America is characterized by strong biomedical research capacity, specialist clinical centers, and demanding evidence and reimbursement environments. Europe combines advanced translational research with harmonized regulatory objectives and varied national health-system procurement practices. Asia-Pacific includes highly developed medical-technology ecosystems alongside rapidly expanding clinical infrastructure, creating diverse routes to adoption. Latin America is influenced by unequal access to specialist care, import dependence, and public-sector procurement. The Middle East is investing in healthcare modernization and specialized services, while Africa presents substantial unmet clinical need alongside constraints involving manufacturing access, distribution, training, and affordability. Across all regions, local evidence, dependable supply, and clinician education are central to sustained use.

Group Insights: Economic and Security Alliances Influence Capability Building

ASEAN markets offer opportunities for regional manufacturing, clinical collaboration, and technology transfer, although regulatory pathways and healthcare capacity differ among members. BRICS economies combine significant scientific and industrial capabilities with varied reimbursement systems and regulatory expectations. The European Union benefits from cross-border scientific collaboration and common regulatory structures, while national purchasing decisions remain important. G7 countries generally contribute advanced research, specialized care, and rigorous evaluation capabilities. GCC states are strengthening healthcare infrastructure and may support centralized procurement and innovation programs. NATO members span mature and emerging health systems, making interoperability, resilient supply chains, and emergency-care applications relevant considerations.

Country Insights: Diverse Capabilities Require Localized Strategies

Australia combines strong clinical research with geographically dispersed care requirements. Brazil has substantial medical expertise but faces regional inequality and procurement complexity. Canada offers advanced research and publicly coordinated healthcare, with evidence and budget impact important to adoption. China has deep manufacturing capacity and a large clinical system, alongside evolving regulatory and quality expectations. France, Germany, Italy, Spain, and the United Kingdom each provide established specialist care and research ecosystems, but market access depends on national or regional evaluation and purchasing processes. India combines a large clinical need with expanding biomedical capability and affordability pressures. Japan emphasizes quality, safety, and precision in a mature healthcare environment. Mexico presents opportunities linked to specialist-care development while maintaining sensitivity to cost and import logistics. Russia’s operating environment is shaped by domestic production priorities and access constraints. South Korea combines advanced medical technology, digital health capabilities, and sophisticated clinical institutions. The United States remains influential in translational research, specialist surgery, and evidence-intensive regulatory and reimbursement pathways.

Action Priorities for Leaders: Prove Outcomes, Build Resilience, and Localize Access

Industry leaders should define a narrow clinical problem and generate comparative evidence tied to outcomes that matter to clinicians, patients, and payers. Manufacturing systems should be designed for reproducibility, sterility assurance, traceability, and scalable quality control from the outset. Partnerships with hospitals and research institutions can improve protocol design, training, and post-market evidence collection. Regional strategies should account for regulatory classification, reimbursement, procurement behavior, cold-chain or storage needs, and local service capacity. Leaders should also establish responsible AI governance, protect sensitive biological and clinical data, and develop supply-chain contingencies for critical raw materials, processing steps, and distribution channels.

Research Methodology: Evidence-Based Assessment of Biological-Patch Conditions

This executive summary uses a structured qualitative assessment of biological-patch development and adoption conditions. The approach considers technology characteristics, clinical applications, regulatory and reimbursement factors, manufacturing requirements, healthcare infrastructure, regional variation, and the role of artificial intelligence. Geographic interpretation is organized across the specified regions, economic and security groups, and countries. Conclusions are limited to observable strategic and operational themes; no market estimates, market shares, forecasts, or company-specific claims are used.

Conclusion: Clinical Proof and Execution Discipline Will Determine Progress

Biological patches have potential across regenerative care, tissue repair, wound management, and localized therapy, but technical novelty alone will not ensure adoption. Progress will depend on reliable biological performance, clear clinical value, regulatory readiness, manufacturability, and fit with local care pathways. Organizations that combine rigorous evidence generation with resilient production, responsible data use, and regionally informed access strategies will be best positioned to translate biological-patch innovation into practical patient benefit.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of dissolvable microneedle array patches for vaccine delivery in emerging markets
5.2. Integration of wearable biosensing capabilities into transdermal patches for real-time health monitoring
5.3. Development of customized 3D printed biological patches for personalized drug delivery regimens
5.4. Advancements in biodegradable polymer formulations enhancing patch bioresorption and patient safety
5.5. Emergence of multi-drug combination patches addressing chronic diseases with controlled release profiles
5.6. Increasing regulatory support for self-administrable biological patches in home healthcare settings
5.7. Growing investment in nanocarrier-enabled patch systems to improve therapeutic molecule stability
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biological Patch Market, by Application
8.1. Introduction
8.2. Cardiovascular
8.2.1. Anti Coagulant
8.2.2. Anti Hypertensive
8.3. Hormonal Therapy
8.3.1. Estrogen Therapy
8.3.2. Testosterone Therapy
8.4. Neurology
8.4.1. Anti Epileptic
8.4.2. Parkinsons Therapy
8.5. Pain Management
8.5.1. High Dose
8.5.2. Low Dose
8.6. Wound Care
8.6.1. Acute Wound Therapy
8.6.2. Burn Therapy
8.6.3. Chronic Wound Therapy
8.6.4. Ulcer Therapy
9. Biological Patch Market, by Product Type
9.1. Introduction
9.2. Matrix Patch
9.2.1. Biological Material
9.2.2. Synthetic Material
9.3. Reservoir Patch
9.3.1. Biological Material
9.3.2. Synthetic Material
9.4. Vapor Patch
9.4.1. Synthetic Material
10. Biological Patch Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Home Care
10.4. Hospitals
11. Biological Patch Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Americas Biological Patch Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Biological Patch Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Biological Patch Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. 3M Company
15.3.2. Smith & Nephew plc
15.3.3. ConvaTec Group Plc
15.3.4. Mölnlycke Health Care AB
15.3.5. Coloplast A/S
15.3.6. Baxter International Inc.
15.3.7. Johnson & Johnson
15.3.8. Integra LifeSciences Holdings Corporation
15.3.9. MiMedx Group, Inc.
15.3.10. Terumo Corporation
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. BIOLOGICAL PATCH MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOLOGICAL PATCH MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BIOLOGICAL PATCH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BIOLOGICAL PATCH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BIOLOGICAL PATCH MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BIOLOGICAL PATCH MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BIOLOGICAL PATCH MARKET: RESEARCHAI
FIGURE 24. BIOLOGICAL PATCH MARKET: RESEARCHSTATISTICS
FIGURE 25. BIOLOGICAL PATCH MARKET: RESEARCHCONTACTS
FIGURE 26. BIOLOGICAL PATCH MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIOLOGICAL PATCH MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOLOGICAL PATCH MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICAL PATCH MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY ANTI COAGULANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY ANTI COAGULANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY ANTI HYPERTENSIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY ANTI HYPERTENSIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY ESTROGEN THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY ESTROGEN THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY TESTOSTERONE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY TESTOSTERONE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY ANTI EPILEPTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY ANTI EPILEPTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY PARKINSONS THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY PARKINSONS THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY HIGH DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY HIGH DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY LOW DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY LOW DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY ACUTE WOUND THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY ACUTE WOUND THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY BURN THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY BURN THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY CHRONIC WOUND THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY CHRONIC WOUND THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY ULCER THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY ULCER THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY BIOLOGICAL MATERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY BIOLOGICAL MATERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY SYNTHETIC MATERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY SYNTHETIC MATERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY BIOLOGICAL MATERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY BIOLOGICAL MATERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY SYNTHETIC MATERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY SYNTHETIC MATERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY SYNTHETIC MATERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY SYNTHETIC MATERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BIOLOGICAL PATCH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS BIOLOGICAL PATCH MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES BIOLOGICAL PATCH MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 147. CANADA BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. CANADA BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. CANADA BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 150. CANADA BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 151. CANADA BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 152. CANADA BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 153. CANADA BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 154. CANADA BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 155. CANADA BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 156. CANADA BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 157. CANADA BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 158. CANADA BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 159. CANADA BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. CANADA BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. CANADA BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2018-2024 (USD MILLION)
TABLE 162. CANADA BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2025-2030 (USD MILLION)
TABLE 163. CANADA BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2018-2024 (USD MILLION)
TABLE 164. CANADA BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2025-2030 (USD MILLION)
TABLE 165. CANADA BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2018-2024 (USD MILLION)
TABLE 166. CANADA BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2025-2030 (USD MILLION)
TABLE 167. CANADA BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. CANADA BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. CANADA BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. CANADA BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 174. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 175. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 176. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 177. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 178. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 179. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 180. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 181. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 182. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 183. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 184. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 185. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2018-2024 (USD MILLION)
TABLE 186. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2025-2030 (USD MILLION)
TABLE 187. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2018-2024 (USD MILLION)
TABLE 188. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2025-2030 (USD MILLION)
TABLE 189. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2018-2024 (USD MILLION)
TABLE 190. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2025-2030 (USD MILLION)
TABLE 191. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. MEXICO BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL PATCH MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 296. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 297. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 298. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 299. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 300. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 301. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 302. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 303. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 304. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 305. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2018-2024 (USD MILLION)
TABLE 308. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2025-2030 (USD MILLION)
TABLE 309. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2018-2024 (USD MILLION)
TABLE 310. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2025-2030 (USD MILLION)
TABLE 311. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2018-2024 (USD MILLION)
TABLE 312. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2025-2030 (USD MILLION)
TABLE 313. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. GERMANY BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 318. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 319. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 320. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 321. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 322. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 323. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 324. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 325. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 326. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 327. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 328. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 329. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 330. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 331. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2018-2024 (USD MILLION)
TABLE 332. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY MATRIX PATCH, 2025-2030 (USD MILLION)
TABLE 333. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2018-2024 (USD MILLION)
TABLE 334. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY RESERVOIR PATCH, 2025-2030 (USD MILLION)
TABLE 335. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2018-2024 (USD MILLION)
TABLE 336. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY VAPOR PATCH, 2025-2030 (USD MILLION)
TABLE 337. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 338. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 339. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 340. FRANCE BIOLOGICAL PATCH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 341. RUSSIA BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 342. RUSSIA BIOLOGICAL PATCH MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 343. RUSSIA BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 344. RUSSIA BIOLOGICAL PATCH MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 345. RUSSIA BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 346. RUSSIA BIOLOGICAL PATCH MARKET SIZE, BY HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 347. RUSSIA BIOLOGICAL PATCH MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)

Companies Mentioned

  • Abbott Laboratories
  • Aesculap, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • BioIntegral Surgical, Inc.
  • Cook Medical LLC
  • CorMatrix Cardiovascular, Inc.
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Getinge AB
  • Integra LifeSciences Corporation
  • Johnson & Johnson
  • LeMaitre Vascular, Inc.
  • Medtronic plc
  • MiMedx Group, Inc.
  • Stryker Corporation
  • Terumo Corporation
  • Tissuemed Ltd
  • W. L. Gore & Associates, Inc.
  • Zimmer Biomet Holdings, Inc.

Related Topics

Related Reports

Cardiovascular Monitoring Skin Patches Market - Global Forecast 2026-2032 - Product Image

Cardiovascular Monitoring Skin Patches Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Bioinductive Implants Market - Global Forecast 2026-2032 - Product Image

Bioinductive Implants Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Nerve Patch Market Report 2026 - Product Image

Nerve Patch Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Transdermal Skin Patches Market Report by Type, Application, Distribution Channel, Countries and Companies Analysis 2026-2034 - Product Image

Transdermal Skin Patches Market Report by Type, Application, Distribution Channel, Countries and Companies Analysis 2026-2034

  • Report
  • 200 Pages
  • Global
From
Extracellular Matrix Patch Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Extracellular Matrix Patch Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.